As the U.S. continues to adapt to the COVID-19 pandemic, there is more attention than ever on the health and wellness space, from COVID vaccines to rapid tests. This ever-changing medical landscape made it essential for advertisers to quickly adjust their spending and creative strategies to keep up with the latest trends.
Pathmatics has recently released new, deeper categories in Explorer, allowing you to find insights into Health & Wellness advertising like never before. Our State of Health & Wellness Ads Report provides an in-depth analysis of the latest advertising trends, from prescription and nonprescription drugs to COVID-19 vaccines to flu shots.
Infection medication ad spending grew rapidly in 2021
In 2019, Infections ranked as the No. 10 subcategory under Prescription & Nonprescription Drugs. Infections brands’ ad spending has climbed following the outbreak of COVID-19 and in 2021 in particular. Top brands in the Infection subcategory included Biktarvy and EPCLUSA from Gilead Sciences, Eli Lily, GlaxoSmithKline, and Pfizer. Pain Relief & Management was the only subcategory with higher spending in 2021.
Comparing this with the same period in 2020, Infections ad spending increased roughly 250 percent to more than $42 million in Q4 2021. In contrast, Metabolic Diseases brands’ ad spending has decreased since its peak in Q3 2020.
To learn more about the data behind this article and what Pathmatics has to offer, visit www.pathmatics.com.
Sign up to receive our stories in your inbox.
Data is changing the speed of business. Investors, Corporations, and Governments are buying new, differentiated data to gain visibility make better decisions. Don't fall behind. Let us help.
Sign up to receive our stories in your inbox.
Data is changing the speed of business. Investors, Corporations, and Governments are buying new, differentiated data to gain visibility make better decisions. Don't fall behind. Let us help.
